CSIMarket
 


Repligen Corp  (RGEN)
Other Ticker:  
 


Repligen's Net Profit Margin by quarter

Trends, Rankings, Statistics



RGEN Net Profit Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change -29.66 % -23.34 % -11.5 % 0.13 % 12.64 %
Seq. Revenue Change -11.29 % -12.86 % -2.2 % -6.96 % -3.32 %
Revenue In Millions $141.19 $159.17 $182.66 $186.76 $200.74
Net Profit Margin 12.87 % 12.61 % 15.78 % 26.09 % 20.13 %
Net Profit Margin Total Ranking # 1126 # 1184 # 987 # 850 # 955
Net Income In Millions $18.17 $20.06 $28.83 $48.73 $40.41
Y / Y Net Income Change -55.03 % -59.76 % -38.61 % 67.4 % 20.62 %
Seq. Net Income Change -9.43 % -30.4 % -40.84 % 20.6 % -18.96 %


Commenting Third Quarter 2023 Net Profit Margin
Repligen Corp increased Net Profit Margin through reduction in total costs and taxes and despite contraction in Net Income by -9.43 % and Revenue by -11.29 %. Net Profit Margin in III. Quarter was 12.87 %, below company average.

Observing third quarter 2023 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Net Profit Margin. While Net Profit Margin total ranking has impoved so far to 1126, from total ranking in previous quarter at 1184.
Net Margin Formula
RGEN's Net Profit Margin third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 11
Healthcare Sector # 89
Overall # 1123

Net Profit Margin Statistics
High Average Low
50.78 % 16.41 % 1.24 %
(Dec 31 2012)   (Dec 31 2015)




Other Net Profit Margin Profitability Ratios
RGEN's Cumulative Net Profit Margin
Biotechnology & Pharmaceuticals Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
RGEN's Net Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for RGEN's Competitors
Net Profit Margin Profit Margin for Repligen's Suppliers
Net Profit Margin Profit Margin for RGEN's Customers

You may also want to know
RGEN's Annual Growth Rates RGEN's Profitability Ratios RGEN's Asset Turnover Ratio RGEN's Dividend Growth
RGEN's Roe RGEN's Valuation Ratios RGEN's Financial Strength Ratios RGEN's Net Income Growth
RGEN's Roa RGEN's Inventory Turnover Ratio RGEN's Growth Rates RGEN's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Net Profit MarginSep 30 2023 MRQ Net IncomeSep 30 2023 MRQ Revenue
Gilead Sciences Inc   30.80 %$ 2,172.000 $ 7,051.000 
Amgen Inc   25.06 %$ 1,730.000 $ 6,903.000 
Fresh Tracks Therapeutics Inc   24.01 %$ 1.907 $ 7.944 
Bio techne Corp  18.46 %$ 50.993 $ 276.191 
Neurocrine Biosciences Inc   16.66 %$ 83.100 $ 498.800 
Repligen Corp  12.87 %$ 18.172 $ 141.192 
Adma Biologics Inc   3.85 %$ 2.565 $ 66.653 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com